BACKGROUND: This study evaluated the midterm outcomes, the valve related events and quality of life of patients treated by valve-sparing aortic root replacement (VSRR). METHODS: From January 2003 to December 2014, 88 consecutive patients diagnosed with an aortic root aneurysm or ascending aortic aneurysms underwent VSRR surgery. The mean age was 55±14 (range 19-77) years. A total of 84% of the patients were male; 89% were in New York Heart Association functional class I or II, 55% had aortic regurgitation (AR) grade III or IV. Twenty-four patients (27.3%) had bicuspid aortic valve. The mean left ventricular ejection fraction (LVEF) was 61%±9% (range 29-78%). Patients were yearly followed by family doctors and referent cardiologists. Doppler echocardiographic examinations were obtained annually in all patients. The midterm clinical, echocardiographic results and quality of life were analyzed. The mean follow-up was 5.3±3 (range 1-12) years. RESULTS: Hospital mortality was 1%. There were 10 late deaths (11%) including 5 cardiac cases. Two patients (2%) required an aortic valve or graft prosthesis reoperation. Aortic valve endocarditis occurred in two patients. Thromboembolic events were reported in three patients. None of the following morbidity has been observed: structural valve deterioration, nonstructural dysfunction, valve thrombosis, bleeding event. The 5- and 8-year survival were 92% and 88%, respectively. The 8-year survival free from cardiac death was 88%. The mean of EuroQoL visual analogue scale (EQ VAS) and EQ index were respectively 83±15 (range 30-100) and 0.94±0.12 (range 0.5-1). CONCLUSIONS: Eight-year clinical improvement, function of the spared aortic valve and quality of life after valve sparing aortic root surgery appear excellent.
BACKGROUND: This study evaluated the midterm outcomes, the valve related events and quality of life of patients treated by valve-sparing aortic root replacement (VSRR). METHODS: From January 2003 to December 2014, 88 consecutive patients diagnosed with an aortic root aneurysm or ascending aortic aneurysms underwent VSRR surgery. The mean age was 55±14 (range 19-77) years. A total of 84% of the patients were male; 89% were in New York Heart Association functional class I or II, 55% had aortic regurgitation (AR) grade III or IV. Twenty-four patients (27.3%) had bicuspid aortic valve. The mean left ventricular ejection fraction (LVEF) was 61%±9% (range 29-78%). Patients were yearly followed by family doctors and referent cardiologists. Doppler echocardiographic examinations were obtained annually in all patients. The midterm clinical, echocardiographic results and quality of life were analyzed. The mean follow-up was 5.3±3 (range 1-12) years. RESULTS: Hospital mortality was 1%. There were 10 late deaths (11%) including 5 cardiac cases. Two patients (2%) required an aortic valve or graft prosthesis reoperation. Aortic valve endocarditis occurred in two patients. Thromboembolic events were reported in three patients. None of the following morbidity has been observed: structural valve deterioration, nonstructural dysfunction, valve thrombosis, bleeding event. The 5- and 8-year survival were 92% and 88%, respectively. The 8-year survival free from cardiac death was 88%. The mean of EuroQoL visual analogue scale (EQ VAS) and EQ index were respectively 83±15 (range 30-100) and 0.94±0.12 (range 0.5-1). CONCLUSIONS: Eight-year clinical improvement, function of the spared aortic valve and quality of life after valve sparing aortic root surgery appear excellent.
Authors: Christian D Etz; Moritz S Bischoff; Carol Bodian; Fabian Roder; Robert Brenner; Randall B Griepp; Gabriele Di Luozzo Journal: J Thorac Cardiovasc Surg Date: 2010-12 Impact factor: 5.209
Authors: Elizabeth H Stephens; David H Liang; John-Peder Escobar Kvitting; Fabian A Kari; Michael P Fischbein; R Scott Mitchell; D Craig Miller Journal: J Thorac Cardiovasc Surg Date: 2013-10-29 Impact factor: 5.209
Authors: Karin M J Verbakel; Albert H M van Straten; Mohamed A Soliman Hamad; Erwin S H Tan; Joost F ter Woorst Journal: Asian Cardiovasc Thorac Ann Date: 2012-08
Authors: Hadi Toeg; Vincent Chan; Rajeev V Rao; Kwan-Leung Chan; Marc Ruel; Thierry Mesana; Munir Boodhwani Journal: Ann Thorac Surg Date: 2014-06-24 Impact factor: 4.330
Authors: Joseph S Coselli; Michael S Hughes; Susan Y Green; Matt D Price; Samantha Zarda; Kim I de la Cruz; Ourania Preventza; Scott A LeMaire Journal: Ann Thorac Surg Date: 2014-01-11 Impact factor: 4.330
Authors: John-Peder Escobar Kvitting; Fabian A Kari; Michael P Fischbein; David H Liang; Anne-Sophie Beraud; Elizabeth H Stephens; R Scott Mitchell; D Craig Miller Journal: J Thorac Cardiovasc Surg Date: 2012-10-17 Impact factor: 5.209
Authors: Joel Price; Laurent De Kerchove; David Glineur; Jean-Louis Vanoverschelde; Philippe Noirhomme; Gebrine El Khoury Journal: Ann Thorac Surg Date: 2012-09-07 Impact factor: 4.330